Orrick Herrington & Sutcliffe LLP advised Rafael Pharmaceuticals on the deal.Rafael Pharmaceuticals, a clinical-stage oncology company, announced its proposed merger with Rafael Holdings, Inc., (NYSE: RFL). The…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
